Current Assets (Annual)

Current Assets: The sum of all assets that are classified as current, because they will provide a benefit within one year.

Merck & Co., Inc. (MRK) had Current Assets of $43.52B for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$65.01B
Net Income	$18.25B
Cost of Goods Sold	$16.38B
Gross Profit	$48.63B
Operating Expenses	$42.90B
Operating Income	$22.11B
Non-Operating Income/Expense	$-1.04B
Pre-Tax Income	$21.07B
Normalized Pre-Tax Income	$21.96B
Income after Taxes	$18.26B
Income from Continuous Operations	$18.26B
Consolidated Net Income/Loss	$18.26B
Normalized Income after Taxes	$19.27B
EBIT	$22.11B
EBITDA	$27.95B
Weighted-Average Shares Outstanding (Basic)	2.50B
Weighted-Average Shares Outstanding (Diluted)	2.51B
Earnings per Share (EPS) (Basic)	$7.30
Earnings per Share (EPS) (Diluted)	$7.28
Balance Sheet Financials
Current Assets	$43.52B
Property, Plant, and Equipment	$25.32B
Long-Term Assets	$93.35B
Total Assets	$136.87B
Current Liabilities	$28.33B
Long-Term Debt	$46.75B
Long-Term Liabilities	$55.88B
Total Liabilities	$84.20B
Common Equity	$52.66B
Tangible Shareholders Equity	$4.40B
Shareholders Equity	$52.66B
Common Shares Outstanding	2.47B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$16.47B
Cash Flow from Investing Activities	$-13.74B
Cash Flow from Financial Activities	$-1.92B
Beginning Cash	$13.32B
End Cash	$14.69B
Increase/Decrease in Cash	$1.37B
Stock-Based Compensation	$820.00M
Common Stock Dividends Paid	$-8.18B
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.54
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.47
Debt to Equity Ratio	0.94
Gross Margin	74.80%
Operating Margin	34.01%
EBIT Margin	34.01%
EBITDA Margin	42.98%
Pre-Tax Profit Margin	32.41%
Profit Margin	28.08%
Free Cash Flow	$12.36B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.47
Inventory Turnover	2.46
Receiveable Turnover	5.52
Days Sales in Receivables	66.11
Return on Equity	34.68%
Return on Tangible Equity	414.88%
Return on Assets	13.34%
Return on Investments	18.37%
Book Value Per Share	$21.28
Free Cash Flow per Share	$4.93
Operating Cash Flow per Share	$6.57

Data from Zacks Investment Research, Inc.